FORGHIERI, Fabio
 Distribuzione geografica
Continente #
NA - Nord America 12.727
EU - Europa 5.036
AS - Asia 4.527
SA - Sud America 581
Continente sconosciuto - Info sul continente non disponibili 250
AF - Africa 119
OC - Oceania 11
Totale 23.251
Nazione #
US - Stati Uniti d'America 12.398
GB - Regno Unito 1.415
SG - Singapore 1.289
CN - Cina 1.100
IT - Italia 1.040
SE - Svezia 597
HK - Hong Kong 582
VN - Vietnam 522
BR - Brasile 422
DE - Germania 421
FI - Finlandia 407
RU - Federazione Russa 283
BD - Bangladesh 249
FR - Francia 233
UA - Ucraina 193
CA - Canada 144
IN - India 141
TR - Turchia 139
KR - Corea 96
BG - Bulgaria 71
NL - Olanda 67
ID - Indonesia 66
JP - Giappone 65
AR - Argentina 53
IL - Israele 45
MX - Messico 45
BE - Belgio 44
ES - Italia 40
IQ - Iraq 40
CZ - Repubblica Ceca 38
IE - Irlanda 28
CR - Costa Rica 26
PL - Polonia 26
LT - Lituania 25
CO - Colombia 23
SC - Seychelles 23
ZA - Sudafrica 23
AE - Emirati Arabi Uniti 22
EC - Ecuador 22
IR - Iran 19
JM - Giamaica 18
CL - Cile 17
AT - Austria 16
MA - Marocco 16
PK - Pakistan 16
UZ - Uzbekistan 16
PY - Paraguay 15
SV - El Salvador 15
AZ - Azerbaigian 14
CH - Svizzera 14
VE - Venezuela 14
BZ - Belize 13
EG - Egitto 13
JO - Giordania 13
EU - Europa 12
PH - Filippine 12
DK - Danimarca 11
KE - Kenya 11
AU - Australia 10
GT - Guatemala 10
HN - Honduras 10
MY - Malesia 10
SA - Arabia Saudita 10
SK - Slovacchia (Repubblica Slovacca) 10
CW - ???statistics.table.value.countryCode.CW??? 9
PR - Porto Rico 9
RO - Romania 8
TN - Tunisia 8
TT - Trinidad e Tobago 8
TW - Taiwan 8
NI - Nicaragua 7
PT - Portogallo 7
BB - Barbados 6
DZ - Algeria 6
GP - Guadalupe 6
GR - Grecia 6
UY - Uruguay 6
AL - Albania 5
CY - Cipro 5
ET - Etiopia 5
LB - Libano 5
NO - Norvegia 5
NP - Nepal 5
PE - Perù 5
PS - Palestinian Territory 5
RS - Serbia 5
TH - Thailandia 5
AM - Armenia 4
OM - Oman 4
PA - Panama 4
QA - Qatar 4
BH - Bahrain 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
EE - Estonia 3
KG - Kirghizistan 3
MD - Moldavia 3
MK - Macedonia 3
SN - Senegal 3
XK - ???statistics.table.value.countryCode.XK??? 3
Totale 22.985
Città #
Ashburn 1.569
Fairfield 1.188
Southend 978
Santa Clara 890
Singapore 825
Woodbridge 746
San Jose 594
Chandler 592
Hong Kong 570
Houston 566
Seattle 457
Ann Arbor 455
Cambridge 357
Wilmington 339
Council Bluffs 335
Nyköping 331
Jacksonville 329
Dearborn 317
Helsinki 314
Hefei 251
New York 228
Beijing 216
Modena 215
London 196
Ho Chi Minh City 169
Los Angeles 168
Hanoi 116
Chicago 111
Milan 108
The Dalles 104
Boardman 99
Munich 98
San Diego 83
Seoul 81
Fremont 73
Sofia 70
Bremen 67
Princeton 67
Lauterbourg 65
Izmir 64
Buffalo 63
Eugene 63
Bologna 62
Dallas 61
Columbus 59
Moscow 56
Shanghai 53
São Paulo 48
Jakarta 43
Rome 43
Toronto 43
Orem 40
Frankfurt am Main 34
Redwood City 34
Atlanta 33
Brussels 32
Brooklyn 31
Montreal 31
Tokyo 31
Salt Lake City 29
Chennai 28
Da Nang 28
Turku 28
Dublin 26
Phoenix 26
Des Moines 24
Denver 21
Naples 20
Paris 20
San Francisco 20
Miami 19
North Bergen 19
Washington 19
Guangzhou 18
Las Vegas 18
Stockholm 17
Dong Ket 16
Tampa 16
Warsaw 16
Baghdad 15
Haiphong 15
Mexico City 15
Miano 15
Tashkent 15
Kingston 14
Mumbai 14
San José 14
Albuquerque 13
Belize City 13
Boston 13
Kunming 13
Rio de Janeiro 13
Amsterdam 12
Brno 12
Deventer 12
Johannesburg 12
Quito 12
Hải Dương 11
Manchester 11
Nairobi 11
Totale 15.964
Nome #
Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis 498
B cells and herpesviruses: a model of lymphoproliferation 489
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 460
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 451
Helicobacter pylori infection andchronic immune thrombocytopenic purpura: long-term results of bacteriumeradication and association with bacterium virulence profiles 436
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 424
An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells? 416
Detection of Pneumocystis jirovecii and Aspergillus spp. DNa in bronchoalveolar lavage fluids by commercial real-time PCr assays: comparison with conventional diagnostic tests 406
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 398
Mucorales-specific T cells in patients with hematologic malignancies 394
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term Imatinib mesylate treatment. 394
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 389
Acute appendicitis in adult neutropenic patients with hematologic malignancies 377
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 376
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 372
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 367
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 363
Cytarabine-related lung infiltrates on high resolution computerized tomography: a possible complication with benign outcome in leukemic patients. 363
An unusual case of splenomegaly and increased lactate dehydrogenase heralding acute myeloid leukemia with eosinophilia and RUNX1-MECOM fusion transcripts 361
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 358
Diagnosis of invasive aspergillosis by tracking Aspergillus-specific T cells in hematologic patients with pulmonary infiltrates 351
Chronic eosinophilic leukaemia with ETV6-NTRK3 fusion transcript in an elderly patient affected with pancreatic carcinoma 345
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 344
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 342
Human herpesvirus 6 latency characterized by high viral load: Chromosomal integration in many, but not all, cells 334
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 334
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 331
Investigating the association between physicians self-efficacy regarding communication skills and risk of “burnout” 328
Organising pneumonia mimicking invasive fungal disease in patients with leukaemia. 327
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 327
Identification and characterization of Aspergillus-specific immune responses to diagnose invasive aspergillosis in high risk patients: a multicenter study 326
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 326
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 319
"Metodo per la diagnosi e/o il monitoraggio della mucormicosi" - "Method for the diagnosis of and/or monitoring mucormycosis" 308
Ruxolitinib for pulmonary extramedullary hematopoiesis in myelofibrosis 307
Human Herpesvirus 8 (HHV8) Infection and Related Diseases in Italian Transplant Cohorts. 307
Epstein-Barr virusassociated pneumonia in an adult patient with severe aplastic anaemia: resolutionafter the transient withdrawal of cyclosporine. 305
Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. 303
Inflammatory myofibroblastic tumor of the bone marrow. 303
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 302
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 301
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 300
The importance of cytogenetic and molecular analyses in eosinophilia-associated myeloproliferative neoplasms: an unusual case with normal karyotype and TNIP1- PDGFRB rearrangement and overview of PDGFRB partner genes 297
HHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role? 297
Pain and emotional distress in leukemia patients at diagnosis. 295
Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia 294
Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia-like or acute lymphoblastic leukemia-like chemotherapy and impact of allogeneic stem cell transplantation: a Campus ALL study 291
Variability of Voriconazole Trough Levels in Haematological Patients: Influence of Comedications with cytochrome P450(CYP) Inhibitors and/or with CYP Inhibitors plus CYP Inducers 288
Indirect Antitumor Effects of Mammalian Target of Rapamycin Inhibitors Against Kaposi Sarcoma in Transplant Patients 285
BK virus infection and neurologic dysfunctions in a patient with lymphoma treated with chemotherapy and rituximab 282
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 280
How I treat HHV8/KSHV-related diseases in posttransplant patients. 279
Pain and emozional distress in hematological patients throughout all phases of disease: results from a multidisciplinary research team in Modena University Hospital 279
Mucorles-specific T cells emerge in the course of invasive mucormucosis and may be used as a surrogate diagnostic marker in high-risk patients 278
Safety profile of Erwinia asparaginase treatment in adults with newly diagnosed acute lymphoblastic leukemia: a retrospective monocenter study 275
Tumor-targeted immunoliposomal nanosystems to deliver either Cidofovir or Antineoplastic SiRNA against Primary Effusion Lymphoma (PEL) 270
Splenic hyalohyphomycosis, molecularly and immunologically consistent with invasive aspergillosis, in a patient with acute lymphoblastic leukemia. 259
Splenomegaly in hematological malignancies and portal hypertension 258
Early palliative/supportive care in acute myeloid leukaemia allows low aggression end-of-life interventions: Observational outpatient study 255
Acute promyelocytic leukemia in very elderly patients: still aclinical challenge. 254
Minimal/Measurable Residual Disease Monitoring in NPM1-Mutated Acute Myeloid Leukemia: A Clinical Viewpoint and Perspectives 248
Interferon-alpha may restore sensitivity to tyrosine-kinase inhibitors in Philadelphia chromosome positive acute lymphoblastic leukaemia with F317L mutation 238
Philadelphia chromosome-positive acute lymphoblastic leukemia 237
Ibrutinib Is a Newly Recognized Host Factor for the Definition of Probable Invasive Pulmonary Mold Disease, Based on Off-target Effects, Unrelated to Its B-cell Immunosuppressant Activity 224
Severe pneumonia caused by Legionella pneumophila serogroup 11, Italy. 217
May the correlation between Kit-D816 mutation and AML1-ETO level change the use of prognostic factors in t(8;21) AML? 217
Persistent hiccups as an adverse event to FLAG-IDA regimenfor leukemia. 210
β-HHVs and HHV-8 in Lymphoproliferative Disorders. 200
Improved efficacy of quizartinib in combination therapy with PI3K inhibition in primary FLT3-ITD AML cells 199
Feasibility of autologous peripheral blood stem cell mobilization and harvest in adult patients with FLT3-mutated acute myeloid leukemia receiving chemotherapy combined with midostaurin: a single-center experience 186
Edmonton symptom assessment system Global Distress Score and overall survival in acute leukaemia 185
Identification and validation of diagnostic cut-offs of the ELISpot assay for the diagnosis of invasive aspergillosis in high-risk patients 171
Preclinical Validation of an Advanced Therapy Medicinal Product Based on Cytotoxic T Lymphocytes Specific for Mutated Nucleophosmin (NPM1mut) for the Treatment of NPM1mut-Acute Myeloid Leukemia 168
The dynamic functions of IRF4 in B cell malignancies 129
Optical genome mapping reveals multiple apoptotic and cell-cycle pathway aberrations in B-cell prolymphocytic leukemia: a report of three cases 79
OPTICAL GENOME MAPPING IDENTIFIES MULTIPLE STRUCTURAL VARIATION AND CATASTROPHIC REARRANGEMENTS IN B-CELL PROLYMPHOCYTIC LEUKEMIA 46
Quality of life and symptoms in acute myeloid leukaemia with early palliative care: real-world observational study 44
CLINICAL OUTCOMES OF YOUNGER ADULT PATIENTS WITH PHILADELPHIANEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA, TREATED IN THE REAL-LIFE WITH A PEDIATRIC-LIKE REGIMEN BASED ON GIMEMA LAL1308 PROTOCOL: AN OBSERVATIONAL RETROSPECTIVE CAMPUS ALL STUDY 39
Hemopoietic stem cell transplantation for infectious mononucleosis-related aplastic anemia 36
Totale 23.251
Categoria #
all - tutte 85.651
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.651


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.020 0 0 0 0 32 71 85 83 140 145 296 168
2022/20231.765 231 219 109 173 273 203 58 169 163 23 72 72
2023/20241.191 33 48 92 88 215 139 137 210 23 22 77 107
2024/20253.149 129 44 72 214 567 464 237 175 397 96 284 470
2025/20266.310 480 241 414 572 884 466 888 331 667 541 492 334
2026/20272.090 182 414 413 916 165 0 0 0 0 0 0 0
Totale 23.251